膀胱癌根治性膀胱切除术中扩大与标准淋巴结清扫的比较
本研究利用SEER-Medicare数据库模拟LEA AUO AB 25/02随机试验,纳入1204例接受根治性膀胱切除术的高级别T1或cT2-T4a、Nany、M0膀胱尿路上皮癌患者,比较扩大淋巴结清扫(eLND,>12枚)与标准淋巴结清扫(sLND,4-11枚)的生存差异。倾向评分调整后,eLND与sLND在5年癌症特异性生存(68% vs 64%;HR 0.83,95%CI 0.64-1.06;HR 0.82,95%CI 0.68-1.01;
要点
- 按T分期、pN分期和年龄亚组分析,结果一致。
核心结论
- 在模拟LEA AUO AB 25/02试验的观察性分析中,eLND与sLND相比未改善癌症特异性生存或总生存。
研究设计与样本
- 利用SEER-Medicare数据库模拟LEA AUO AB 25/02临床试验的观察性研究。
- 纳入2000-2017年诊断为高级别T1或cT2-T4a、Nany、M0膀胱尿路上皮癌并接受根治性膀胱切除术加淋巴结清扫的66-79岁成人。
- 共纳入1204例患者,其中794例接受eLND,410例接受sLND;sLND定义为清扫4-11枚淋巴结,eLND定义为清扫>12枚淋巴结;采用倾向评分调整。
主要发现
- 按T分期、pN分期和年龄分析治疗效应异质性,结果相似。
临床怎么用
- 对于接受根治性膀胱切除术的膀胱癌患者,扩大淋巴结清扫未显示生存获益,支持标准淋巴结清扫的合理性。
局限性
- 为观察性模拟研究,非随机对照试验,可能存在未测量混杂。
- 淋巴结清扫范围定义基于淋巴结计数(4-11 vs >12枚),可能受病理评估差异影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The oncologic benefit of the extent of lymphadenectomy at the time of radical cystectomy (RC) for bladder cancer is uncertain. Although two randomized clinical trials have reported no difference in disease-free or overall survival for extended LND (eLND) compared to standard LND (sLND), real-world data are lacking. We therefore emulated a pragmatic clinical trial using a large, nationwide dataset. METHODS: We used SEER-Medicare to emulate the LEA AUO AB 25/02 clinical trial. We identified adults 66-79 years diagnosed with high-grade T1 or cT2-T4a, Nany, M0 urothelial carcinoma of the bladder from 2000 to 2017 and treated with RC with LND. sLND and eLND were defined as removal of 4-11 and >12 lymph nodes, respectively. A propensity score (PS) was estimated for receipt of eLND. Associations of LND type with cancer-specific (CSS) and overall survival (OS) were evaluated. RESULTS: A total of 1204 patients were included in the study cohort, of whom 794 underwent eLND and 410 underwent sLND. Pre-treatment characteristics were well-balanced after PS adjustment. Compared to sLND, eLND was not associated with a statistically significant difference in 5-year CSS (68% vs 64%; HR 0.83, 95% CI 0.64-1.06; P = .14) or OS (56% vs 55%; HR 0.82; 95% CI 0.68-1.01; P = .06). Results were similar when examining heterogeneity of treatment effects according to T stage, pN stage and age. CONCLUSION: In observational analyses designed to emulate the completed LEA AUO AB 25/02 trial, eLND was not associated with improved CSS or OS compared to sLND among patients undergoing RC.
引用
- Almohtasib J, Scire E, Kaul S, et al. Extended vs Standard Lymph Node Dissection at the Time of Radical Cystectomy for Bladder Cancer. Urology. 2026. PMID: 42361989. doi:10.1016/j.urology.2026.06.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。